13F GuideFiling Basics
What is SEC Form 13F? Ultimate Guide to Institutional Equity Filings
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
AlphaSMO Research GuideRead Guide
CIK: 0001595725
Total reported value
$2.0B
$2.0B
109 檔
32.6%
During the Q3 2024 filing period, Rock Springs Capital Management LP (CIK: 0001595725) submitted its Form 13F report to the U.S. SEC, disclosing a tracked public equity portfolio valued at $2.0B across 109 reported positions.
Rock Springs Capital Management LP executed strategic sector rebalancing during Q3 2024, establishing 6 new positions while fully exiting 7 holdings and trimming 31 positions.
In terms of portfolio concentration, the top 5 core holdings (including UNH, ISRG, ARGX) accounted for 32.6% of total reported equity market value during Q3 2024.
Top New Position Initiated
SMMT
市值: $22.8M
Top Position Liquidated / Trimmed
IDXX
前期市值: $58.2M
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | UNH | Unitedhealth Group Inc | Stock-Healthcare | 5.60% | +0.44% | +7.00% | |
| 2 | ISRG | Intuitive Surgical Inc | Stock-Healthcare | 4.32% | -0.75% | -9.55% | |
| 3 | ARGX | Argenx Se - Adr | Stock-Healthcare | 4.12% | -1.85% | +1.85% | |
| 4 | LLY | Eli Lilly & Co | Stock-Healthcare | 4.09% | +0.43% | +16.87% | |
| 5 | RARE | Ultragenyx Pharmaceutical In | Stock-Other | 3.58% | +0.08% | +2.82% | |
| 6 | NBIX | Neurocrine Biosciences Inc | Stock-Healthcare | 3.52% | +0.02% | -0.11% | |
| 7 | EXK | Exact Sciences CORP | Stock-Materials | 2.54% | — | +6.10% | |
| 8 | 2655787D | Blueprint Medicines CORP | Stock-Other | 2.31% | — | -69.46% | |
| 9 | ALNY | Alnylam Pharmaceuticals Inc | Stock-Healthcare | 2.24% | -0.46% | — | |
| 10 | TVTX | Travere Therapeutics Inc | Stock-Other | 2.13% | +3.45% | +4.51% | |
| 11 | RYTM | Rhythm Pharmaceuticals Inc | Stock-Other | 2.09% | +0.21% | -4.09% | |
| 12 | MIRM | Mirum Pharmaceuticals Inc | Stock-Other | 2.01% | +0.14% | -10.81% | |
| 13 | FRPT | Freshpet Inc | Stock-Consumer Staples | 1.99% | — | -6.98% | |
| 14 | EVH | Evolent Health Inc - A | Stock-Other | 1.90% | +0.30% | -49.23% | |
| 15 | MDGL | Madrigal Pharmaceuticals Inc | Stock-Healthcare | 1.82% | -0.69% | +7.15% | |
| 16 | PHR | Phreesia Inc | Stock-Other | 1.69% | +0.05% | -5.58% | |
| 17 | XENE | Xenon Pharmaceuticals Inc | Stock-Other | 1.69% | -0.61% | +3.43% | |
| 18 | ACHC | Acadia Healthcare Co Inc | Stock-Other | 1.68% | -0.10% | EXIT | |
| 19 | PEN | Penumbra Inc | Stock-Healthcare | 1.68% | -0.55% | — | |
| 20 | WST | West Pharmaceutical Services | Stock-Healthcare | 1.64% | — | +15.29% | |
| 21 | INSM | Insmed Inc | Stock-Healthcare | 1.62% | -1.15% | -15.46% | |
| 22 | KYMR | Kymera Therapeutics Inc | Stock-Other | 1.62% | +0.10% | -9.84% | |
| 23 | ASND | Ascendis Pharma A/S | Stock-Other | 1.58% | -2.62% | EXIT | |
| 24 | HUM | Humana Inc | Stock-Healthcare | 1.53% | — | +0.40% | |
| 25 | GPCR | Structure Therapeutics Inc | Stock-Other | 1.52% | -0.14% | -0.15% | |
| 26 | RVMD | Revolution Medicines Inc | Stock-Healthcare | 1.49% | +3.17% | +7.08% | |
| 27 | ✓ | Merus N V | Stock-Other | 1.45% | — | -10.84% | |
| 28 | NUVL | Nuvalent Inc-a | Stock-Other | 1.43% | — | +67.97% | |
| 29 | MREO | Mereo Biopharma Group Pl-adr | Stock-Other | 1.27% | — | +2.70% | |
| 30 | BSX | Boston Scientific CORP | Stock-Healthcare | 1.25% | -0.81% | -43.73% | |
| 31 | SRPT | Sarepta Therapeutics Inc | Stock-Healthcare | 1.25% | — | +8.27% | |
| 32 | EW | Edwards Lifesciences CORP | Stock-Healthcare | 1.24% | -0.14% | EXIT | |
| 33 | CLDX | Celldex Therapeutics Inc | Stock-Other | 1.22% | +0.05% | -21.10% | |
| 34 | AGL | agilon health, inc. | Stock-Other | 1.16% | — | +2.21% | |
| 35 | DXCM | Dexcom Inc | Stock-Healthcare | 1.14% | -0.19% | +4.80% | |
| 36 | IMVT | Immunovant Inc | Stock-Other | 1.13% | — | +3.01% | |
| 37 | ZLAB | Zai Lab Ltd-adr | Stock-Other | 1.03% | -0.14% | +1.37% | |
| 38 | PODD | Insulet CORP | Stock-Healthcare | 1.01% | — | -31.28% | |
| 39 | AGIO | Agios Pharmaceuticals Inc | Stock-Other | 1.01% | -0.63% | -33.03% | |
| 40 | IRTC | Irhythm Holdings Inc | Stock-Healthcare | 0.96% | -0.25% | — | |
| 41 | ALGN | Align Technology Inc | Stock-Healthcare | 0.95% | — | -10.20% | |
| 42 | BCRX | Biocryst Pharmaceuticals Inc | Stock-Other | 0.90% | — | +0.09% | |
| 43 | INSP | Inspire Medical Systems Inc | Stock-Healthcare | 0.89% | +0.13% | — | |
| 44 | AKRO | Akero Therapeutics Inc | Stock-Other | 0.87% | — | -13.11% | |
| 45 | AZTA | Azenta Inc | Stock-Other | 0.84% | -0.21% | -23.49% | |
| 46 | LEGN | Legend Biotech Corp-adr | Stock-Other | 0.81% | +0.01% | +0.62% | |
| 47 | WRBY | Warby Parker Inc-class A | Stock-Other | 0.76% | — | -30.81% | |
| 48 | SMMT | Summit Therapeutics Inc | Stock-Other | 0.74% | -0.28% | — | |
| 49 | LFST | Lifestance Health Group Inc | Stock-Other | 0.71% | — | -35.77% | |
| 50 | OSCR | Oscar Health Inc - Class A | Stock-Healthcare | 0.70% | — | -19.18% |
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|---|---|---|---|---|
| 1 | UNH | Unitedhealth Group Inc | +1.4% | +7.00% | Add |
| 2 | RARE | Ultragenyx Pharmaceutical In | +1.2% | +2.82% | Add |
| 3 | EXK | Exact Sciences CORP | +1.2% | +6.10% | Add |
| 4 | ARGX | Argenx Se - Adr | +1.2% | +1.85% | Add |
| 5 | TVTX | Travere Therapeutics Inc | +1% | +4.51% | Add |
| 6 | NUVL | Nuvalent Inc-a | +0.9% | +67.97% | Add |
| 7 | LLY | Eli Lilly & Co | +0.8% | +16.87% | Add |
| 8 | SMMT | Summit Therapeutics Inc | +0.7% | NEW | New buy |
| 9 | KYMR | Kymera Therapeutics Inc | +0.6% | -9.84% | Trim |
| 10 | RYTM | Rhythm Pharmaceuticals Inc | +0.5% | -4.09% | Trim |
| 11 | ZBIO | Zenas Biopharma Inc | +0.5% | NEW | New buy |
| 12 | ALNY | Alnylam Pharmaceuticals Inc | +0.4% | — | Unchanged |
| 13 | RVMD | Revolution Medicines Inc | +0.4% | +7.08% | Add |
| 14 | ASND | Ascendis Pharma A/S | +0.4% | +12.07% | Add |
| 15 | BCAX | Bicara Therapeutics Inc | +0.4% | NEW | New buy |
| 16 | INSP | Inspire Medical Systems Inc | +0.4% | — | Unchanged |
| 17 | CYTK | Cytokinetics Inc | +0.4% | NEW | New buy |
| 18 | ZLAB | Zai Lab Ltd-adr | +0.4% | +1.37% | Add |
| 19 | ISRG | Intuitive Surgical Inc | +0.3% | -9.55% | Trim |
| 20 | XNCR | Xencor Inc | +0.3% | NEW | New buy |
| 21 | APLT | Applied Therapeutics Inc | +0.3% | +12.31% | Add |
| 22 | MREO | Mereo Biopharma Group Pl-adr | +0.3% | +2.70% | Add |
| 23 | GPCR | Structure Therapeutics Inc | +0.3% | -0.15% | Trim |
| 24 | PEN | Penumbra Inc | +0.2% | — | Unchanged |
| 25 | BCRX | Biocryst Pharmaceuticals Inc | +0.2% | +0.09% | Add |
| 26 | WST | West Pharmaceutical Services | +0.2% | +15.29% | Add |
| 27 | XENE | Xenon Pharmaceuticals Inc | +0.2% | +3.43% | Add |
| 28 | NAMS | NewAmsterdam Pharma Company N.V. | +0.2% | NEW | New buy |
| 29 | IMVT | Immunovant Inc | +0.2% | +3.01% | Add |
| 30 | MIRM | Mirum Pharmaceuticals Inc | +0.2% | -10.81% | Trim |
| 31 | CMPX | Compass Therapeutics Inc | +0.2% | +2.09% | Add |
| 32 | ✓ | Inozyme Pharma Inc | +0.2% | +2.83% | Add |
| 33 | PHR | Phreesia Inc | +0.2% | -5.58% | Trim |
| 34 | NMRA | Neumora Therapeutics Inc | +0.1% | +8.96% | Add |
| 35 | LEGN | Legend Biotech Corp-adr | +0.1% | +0.62% | Add |
| 36 | VERA | Vera Therapeutics Inc | +0.1% | +0.60% | Add |
| 37 | FRPT | Freshpet Inc | +0.1% | -6.98% | Trim |
| 38 | AKRO | Akero Therapeutics Inc | +0.1% | -13.11% | Trim |
| 39 | OSCR | Oscar Health Inc - Class A | +0.1% | -19.18% | Trim |
| 40 | CRNX | Crinetics Pharmaceuticals In | +0.1% | — | Unchanged |
| 41 | BHVN | Biohaven Ltd. | +0.1% | — | Unchanged |
| 42 | AUPH | Aurinia Pharmaceuticals Inc | +0.1% | — | Unchanged |
| 43 | LUNG | Pulmonx CORP | +0.1% | +5.96% | Add |
| 44 | AM6 | Amicus Therapeutics Inc | +0.1% | +2.60% | Add |
| 45 | CATX | Perspective Therapeutics Inc | +0.1% | +3.29% | Add |
| 46 | ELVN | Enliven Therapeutics Inc | +0.1% | — | Unchanged |
| 47 | CGEM | Cullinan Therapeutics Inc | +0.1% | +11.94% | Add |
| 48 | DYN | Dyne Therapeutics Inc | +0.1% | — | Unchanged |
| 49 | BMEA | Biomea Fusion Inc | 0% | — | Unchanged |
| 50 | CYPH | Cypherpunk Technologies Inc | 0% | — | Unchanged |
According to official SEC Form 13F filings, Rock Springs Capital Management LP reported a total U.S. public equity portfolio value of $2.0B across 109 disclosed positions in Q3 2024.
During Q3 2024, Rock Springs Capital Management LP's top holdings by market value included UNH (5.6%)、ISRG (4.3%)、ARGX (4.1%). The largest single position, UNH, represented 5.6% of total portfolio value.
In Q3 2024, Rock Springs Capital Management LP made 77 total portfolio adjustments, initiating 6 new buys, adding to 33 positions, trimming 31 holdings, and fully liquidating 7 stocks.
All holding records on this page are fetched directly from the U.S. Securities and Exchange Commission (SEC) EDGAR system (Form 13F-HR). AlphaSMO parses CUSIP identifiers and formats data into Schema.org-compliant datasets.
Expert Analysis & Guides for Tracking Wall Street Smart Money Movements
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
Understand SEC Form 4 insider disclosures for corporate officers, directors, and 10% owners to track executive transactions.
Understand Rule 144 restricted stock sale notices to spot planned insider liquidations before market sell pressure arrives.
Explore the 5% beneficial ownership threshold, 13D vs 13G filing differences, and recent SEC accelerated deadline rules.
Best practices for analyzing 13F quarterly changes without getting misled by stock splits, options, or market valuation drift.
Learn how AlphaSMO's flagship signal detects high-conviction stocks where 13F hedge funds and corporate insiders buy at the same time.